Earnings ·
Hyperfine reports preliminary Q3 revenue of $6.0M, up 53% sequentially
HYPRHyperfine, Inc.
Hyperfine announced preliminary unaudited financial results for the third quarter ended September 30, 2026, reporting estimated total revenue of approximately $6.0 million, representing a 53% sequential increase from the second quarter. For the nine months ended September 30, 2026, estimated revenue was approximately $13.8 million, up 66% year-over-year. The company also reported preliminary net cash burn of approximately $5.6 million for the quarter, a 29% sequential improvement, and expected cash and cash equivalents of approximately $37.9 million as of September 30, 2026. Management reaffirmed its full-year 2026 revenue outlook of approximately $20 to $22 million. Hyperfine is a health technology company that develops the Swoop system, the first FDA-cleared AI-powered portable MRI for brain imaging.